Trial Profile
Removal of Dolutegravir by Hemodialysis in HIV-infected Patients With End-stage Renal Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2020
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Acronyms DTG_HD
- 25 Feb 2016 Results presented at the 23rd Conference on Retroviruses and Opportunistic Infections
- 30 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jul 2015 New trial record